Dina Johnson

483 total citations
9 papers, 384 citations indexed

About

Dina Johnson is a scholar working on Reproductive Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Dina Johnson has authored 9 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Reproductive Medicine, 3 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Dina Johnson's work include Ovarian cancer diagnosis and treatment (4 papers), Intraperitoneal and Appendiceal Malignancies (2 papers) and Ethics in Clinical Research (1 paper). Dina Johnson is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Intraperitoneal and Appendiceal Malignancies (2 papers) and Ethics in Clinical Research (1 paper). Dina Johnson collaborates with scholars based in United States and Malawi. Dina Johnson's co-authors include Bruce J. Roth, G. R. Hudes, Donna Neuberg, Jessica L. Smith, Robert Dreicer, Sidney Schultz, Lawrence H. Einhorn, Patrick J. Loehrer, Roy A. Jensen and John D. Hainsworth and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Medical Informatics Association and Gynecologic Oncology.

In The Last Decade

Dina Johnson

7 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dina Johnson United States	7	261	135	89	66	64	9	384
Valeria Visconti Italy	12	93 0.4×	135 1.0×	77 0.9×	103 1.6×	13 0.2×	22	352
Teruo Kaiga Japan	11	157 0.6×	144 1.1×	40 0.4×	24 0.4×	227 3.5×	24	442
Marta Parera Spain	8	111 0.4×	154 1.1×	67 0.8×	22 0.3×	71 1.1×	9	322
J Rahhal Austria	7	102 0.4×	101 0.7×	34 0.4×	191 2.9×	24 0.4×	8	336
Yasunari Uekado Japan	10	213 0.8×	47 0.3×	45 0.5×	28 0.4×	55 0.9×	37	279
Paola Migliora Italy	7	51 0.2×	112 0.8×	59 0.7×	103 1.6×	27 0.4×	12	239
Patrick Timmins United States	10	90 0.3×	63 0.5×	79 0.9×	108 1.6×	45 0.7×	21	411
Wenhua Zhi China	11	54 0.2×	81 0.6×	102 1.1×	81 1.2×	35 0.5×	18	275
Helen Gay United States	6	231 0.9×	61 0.5×	78 0.9×	26 0.4×	55 0.9×	7	344
Yasuhiko Sawa Japan	5	200 0.8×	117 0.9×	31 0.3×	104 1.6×	109 1.7×	6	366

Countries citing papers authored by Dina Johnson

Since Specialization

Citations

This map shows the geographic impact of Dina Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Johnson more than expected).

Fields of papers citing papers by Dina Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Johnson. The network helps show where Dina Johnson may publish in the future.

Co-authorship network of co-authors of Dina Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Dina Johnson. A scholar is included among the top collaborators of Dina Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina Johnson. Dina Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Abboud, Sarah, Natasha Crooks, Chifundo Zimba, et al.. (2025). Community Stakeholders’ Perspectives on Recruiting Young Adolescents (Age 10–14) in Sexual Health Research. Healthcare. 13(14). 1711–1711.

Al-Khaled, Tala, Emily Cole, Nita Valikodath, et al.. (2020). POSTERIOR TRACTIONAL MEMBRANES FOLLOWING ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR FOR RETINOPATHY OF PREMATURITY. Retinal Cases & Brief Reports. 16(5). 576–580.

Niland, Joyce C., et al.. (2011). Improving patient safety via automated laboratory-based adverse event grading. Journal of the American Medical Informatics Association. 19(1). 111–115. 9 indexed citations

Morgan, Robert J., Lucille Leong, Stephen Shibata, et al.. (2000). Phase II Trial of Combination Intraperitoneal Cisplatin and 5-Fluorouracil in Previously Treated Patients with Advanced Ovarian Cancer: Long-Term Follow-up. Gynecologic Oncology. 77(3). 433–438. 15 indexed citations

Johnson, Dina, et al.. (1999). 5-Fluorouracil simultaneously maintains methotrexate antineoplastic activity in human breast cancer and protects against methotrexate cytotoxicity in human bone marrow.. PubMed. 19(2A). 985–8. 6 indexed citations

Tait, David L., Patrice S. Obermiller, Roy A. Jensen, et al.. (1997). A phase I trial of retroviral BRCA1sv gene therapy in ovarian cancer.. PubMed. 3(11). 1959–68. 49 indexed citations

Morgan, Robert J., James L. Speyer, James H. Doroshow, et al.. (1995). Modulation of 5-Fluorouracil with High-Dose Leucovorin Calcium: Activity in Ovarian Cancer and Correlation with CA-125 Levels. Gynecologic Oncology. 58(1). 79–85. 18 indexed citations

Roth, Bruce J., Robert Dreicer, Lawrence H. Einhorn, et al.. (1994). Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group.. Journal of Clinical Oncology. 12(11). 2264–2270. 271 indexed citations

Garrow, George C., John D. Hainsworth, & Dina Johnson. (1992). PROLONGED ADMINISTRATION OF ORAL ETOPOSIDE IN PREVIOUSLY TREATED EPITHELIAL OVARIAN CANCER. A PHASE II TRIAL. 11. 236–236. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact